Severe Central Hypoventilation Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of the Literature

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Nov 30

PMID 36447716

Authors

Maria Voronova

Artem Sharko

Affiliations

Soon will be listed here.

Abstract

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a condition that is characterized by a variety of psychiatric and neurological symptoms, including central hypoventilation syndrome (CHS). CHS presents with apnea or hypopnea and can vary in severity and rapidity of development but rarely leads to respiratory failure that requires mechanical ventilation. Our patient was diagnosed with anti-NMDAR encephalitis after he presented with classic symptoms, and cerebrospinal fluid analysis showed positive N-methyl-D-aspartate (NMDA) receptor antibodies. During the course of the disease, he developed CHS, which led to respiratory arrest. After treatment with corticosteroids, intravenous immunoglobulin, and plasma exchange, the patient's symptoms improved with complete resolution of the apneic episodes.

References

Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

Trang H, Samuels M, Ceccherini I, Frerick M, Garcia-Teresa M, Peters J . Guidelines for diagnosis and management of congenital central hypoventilation syndrome. Orphanet J Rare Dis. 2020; 15(1):252. PMC: 7503443. DOI: 10.1186/s13023-020-01460-2. View

Blattner M, de Bruin G, Bucelli R, Day G . Sleep disturbances are common in patients with autoimmune encephalitis. J Neurol. 2019; 266(4):1007-1015. PMC: 6421090. DOI: 10.1007/s00415-019-09230-2. View

Zhang T, Duan Y, Ye J, Xu W, Shu N, Wang C . Brain MRI Characteristics of Patients with Anti--Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome. AJNR Am J Neuroradiol. 2018; 39(5):824-829. PMC: 7410660. DOI: 10.3174/ajnr.A5593. View

Barry H, Byrne S, Barrett E, Murphy K, Cotter D . Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015; 39(1):19-23. PMC: 4495821. DOI: 10.1192/pb.bp.113.045518. View

Shin Y, Lee S, Park K, Jung K, Jung K, Lee S . Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2018; 11:1756285617722347. PMC: 5784571. DOI: 10.1177/1756285617722347. View

Lin K, Lin J . Neurocritical care for Anti-NMDA receptor encephalitis. Biomed J. 2020; 43(3):251-258. PMC: 7424095. DOI: 10.1016/j.bj.2020.04.002. View

Graus F, Titulaer M, Balu R, Benseler S, Bien C, Cellucci T . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15(4):391-404. PMC: 5066574. DOI: 10.1016/S1474-4422(15)00401-9. View

Lee W, Lee S, Byun J, Sunwoo J, Kim T, Lim J . Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology. 2016; 86(18):1683-91. DOI: 10.1212/WNL.0000000000002635. View

10.

Varela O J, Sepulveda I G, Sepulveda C J, Acuna L R, Pizarro T G, Maldonado U V . Diaphragm pacing in a pediatric patient with Acquired Central Hypoventilation syndrome. Rev Chil Pediatr. 2020; 91(2):255-259. DOI: 10.32641/rchped.v91i2.1144. View

11.

Lee W, Lee S, Moon J, Sunwoo J, Byun J, Lim J . Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study. Neurotherapeutics. 2016; 13(4):824-832. PMC: 5081109. DOI: 10.1007/s13311-016-0442-6. View

12.

Gillinder L, Warren N, Hartel G, Dionisio S, OGorman C . EEG findings in NMDA encephalitis - A systematic review. Seizure. 2019; 65:20-24. DOI: 10.1016/j.seizure.2018.12.015. View

13.

Lim J, Lee S, Moon J, Jun J, Park B, Byun J . New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2. J Neuroimmunol. 2016; 299:107-111. DOI: 10.1016/j.jneuroim.2016.09.001. View

14.

Uy C, Binks S, Irani S . Autoimmune encephalitis: clinical spectrum and management. Pract Neurol. 2021; 21(5):412-423. PMC: 8461404. DOI: 10.1136/practneurol-2020-002567. View

15.

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M, Balice-Gordon R . Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2010; 10(1):63-74. PMC: 3158385. DOI: 10.1016/S1474-4422(10)70253-2. View

16.

Wang W, Zhang L, Chi X, He L, Zhou D, Li J . Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis. Front Neurol. 2020; 10:1330. PMC: 6993807. DOI: 10.3389/fneur.2019.01330. View